Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODA-AD: Abrocitinib Dose Tapering in Atopic Dermatitis
NCT07848074Phase 4Not yet recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2026
- Primary completion
- May 2027
01
Overview
A Phase 4 trial of abrocitinib in atopic dermatitis (AD), sponsored by Policlinico Gemelli. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
abrocitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07848074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848074.